Co-producing a Novel Model an Outcome Framework for the Implementation of Falls Management in Care Home Settings. (CHAFFINCH)

November 20, 2025 updated by: University of Nottingham

AIM: To co-produce a novel model for implementation of falls management for older people living in care homes

SECONDARY OBJECTIVES

Component One Objectives:

Primary :To co-produce a novel model for the implementation of falls management in care homes Secondary

  • To facilitate a series of co-production workshops with representation of key stakeholders
  • To co-produce a novel implementation model for falls management
  • To co-produce an outcomes framework to evaluate the implementation model
  • To explore the feasibility of delivering the model and using the outcomes framework across Nottingham and Nottinghamshire Integrated Care Systems (ICSs)

Component Two Objectives:

  • To evaluate how and the extent to which co-production occurs during the process of developing a novel model and an outcomes framework for the implementation for falls management in care homes
  • To reflect on challenges and facilitators of using co-production approaches in this context
  • To evaluate how care home residents can be supported to voice their priorities within the process.

Study Overview

Detailed Description

Component One: Co-production of the implementation model and outcomes framework A series of co-production workshops will be undertaken using a systemic action research methodology to develop and explore the feasibility of a novel implementation model and outcomes framework. This will involve three small workshop groups consisting of residents and relatives, care home staff only, and representatives from ICS partner organisations. All participants will be invited to attend a multi-stakeholder workshop in the later stages of the process to share ideas. Data collected for component one will be collected by the PI and PhD student. The novel model will be co-produced as part of this project but may include activities such as a care home audit programme, a reporting process, training and education and a community of practice. Following co-production of the model it will be delivered across Nottinghamshire ICB and refined in line with the systemic action research process.

Component Two: Evaluating the co-production process A process evaluation will be undertaken to explore how and the extent to which co-production occurs in component one, including reflection on challenges and facilitators, and how resident involvement is supported. Data collected for component two will be collected by the PhD student.

Study Type

Observational

Enrollment (Actual)

31

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Care home staff, residents and ICS stakeholders

Description

Inclusion Criteria:

- Key stakeholders within an ICS system including: carers, registered health professionals, managers and owners/executives from care homes commissioners, health care professionals and regulators involved in care home and falls management pathways, residents living in care homes relatives of residents living in care homes

  • 18 years and over (no upper age limit)
  • Any member of staff working in the 10 case study care homes in Nottinghamshire

Exclusion Criteria:

  • Unable to read and understand written English
  • Lack of capacity to give informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Stakeholder

Stakeholder across the ICS: Key stakeholders within an ICS system including:

carers, registered health professionals, managers and owners/executives from care homes commissioners, health care professionals and regulators involved in care home and falls management pathways residents living in care homes relatives of residents living in care homes

Co-design workshops to develop the implementation model
Care home staff
Any member of staff working in the case study care homes
Survey of care staff knowledge and confidence
Interview to explore care staff experience of the falls management support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Key features of the falls management implementation model and outcomes framework using thematic analysis from the co-design workshops through study completion anticipated at 18 months
Time Frame: From enrolment to the end of the co-design workshops at 12 months

The data collected to address this primary includes:

  • The number of workshops, location, duration and range of stakeholders attending
  • Summary of key themes from each meeting drawn together from flipcharts, online flipchart programmes such as padlet and field notes
  • Cross-comparison of themes between the stakeholder groups
  • Record of between meeting activities to describe the types of information and activities undertaken
  • List of problems and potential solutions
  • Facilitator maintained notes on the decisions made in developing the model and the factors influencing the decisions
  • Description of the key features of the model Description of outcomes framework
From enrolment to the end of the co-design workshops at 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Katie Robinson, University of Nottingham

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 2, 2023

Primary Completion (Actual)

March 18, 2025

Study Completion (Actual)

March 18, 2025

Study Registration Dates

First Submitted

April 4, 2025

First Submitted That Met QC Criteria

April 24, 2025

First Posted (Actual)

April 27, 2025

Study Record Updates

Last Update Posted (Actual)

November 24, 2025

Last Update Submitted That Met QC Criteria

November 20, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Due to the small number of participants

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe